| Abstract: | Summary
Psoriasis can have a significant impact on patients’ life, depending on disease severity. Symptoms of psoriasis are not limited to physical impact; they can also have strong psychosocial effects resulting in impaired emotional state, daily activity and body image. Psoriasis has been shown to have an adverse impact on patients’ occupation, sexual functioning, social life and different leisure time activities.
The existing study was carried out using a descriptive design.  It  was conducted at dermatology outpatient clinic at Zagazig University hospitals with  the participation  of  a  purposive  sample  of  120  patients diagnosed with  psoriasis. The data were collected by four tools; an interview questionnaire about socio-demographic and disease characteristic, Illness Cognition Questionnaire (ICQ), Self-administered Simplified Psoriasis Index-severity (saSPI-s) and Arabic version of Dermatology Life Quality Index (DLQI). A pilot study was done on 12 patients and the fieldwork extended from the beginning of September 2020 to the end of February 2021.
The study revealed the following findings:
	Considering the demographic characteristics; the mean age of the studied psoriasis  patients  was  40.29  ± 16.67  years  and  59.2%  of  them  were males.  Also,  73.3%  of  the  patients  were  married  and  65.0%  came from rural  areas. Regarding their educational level, 39.2% of them were university educated.  As it is obvious, 58 % of the patients were working, and the main job was workers (63.8%). For 98.3% of the participants, the crowding  index  was  less  than  two  persons  per  room  and  the income  of 61.2%  of them  had  sufficient  and saving. In  addition,  all  of  the  patients were  having  all  three utilities  in  their  homes.
	 Referring  to  the  level  of illness  cognition,  about 76.7%  of  the  studied psoriasis patients  had  low illness cognition.
	Pertaining   to   the   psoriasis   severity,   patients showed mild, moderate and sever psoriasis 51.7%, 40.8% and 7.5%, respectively.
	According   to   the   total DLQI, 18.3% of patients reported that their disease did not affect their life at all. Meanwhile, 28.3 % and 26.7 % of them reported that their disease moderately and severely affecting their life, respectively. 
	Patient's illness cognition had only positive correlation with the duration of the disease (r=.218). Meanwhile, psoriasis severity score had positive correlation with   duration   of   the   disease   (r=.196), and a negative correlation with patient's commitment with treatment (r=-.258).  On  the  other  hand,  DLQI  scores  had  positive  correlation  with gender  (r=.199),  and  a  negative  correlation  with age  (r=-.226)  and commitment with treatment  (r=-.229).
	Multivariate analyses revealed that:
	Patient's    age,    occupation,    family    income,   commitment    with treatment instruction,  and  number of  treatment  were  statistically significant  negative predictors  of  their  illness  cognition.  Conversely, gender, residence, educational level and disease duration were positive ones.
	Marital status was statistically significant independent negative predictor of psoriasis severity scores. On the other hand, duration of disease, number of treatment and illness cognition score were positive ones.
	Patient's age was the only negative predictor of their DLQI scores. Conversely, illness cognition and psoriasis severity score were the positive predictors.
Conclusion & Recommendations:
The study results concluded that the majority of the studied psoriasis patients had low illness cognition. Also, psoriasis severity ranged mostly from mild to moderate with few severe cases. In addition, illness cognition and psoriasis severity significantly affected the daily life of the patients.
The  study  recommends health education  to  all  newly diagnosed patients about  the  disease  and the importance  of treatment adherence with continuous updating  follow up. As well as further research is needed for better understanding of the effect of various factors on the patient's daily life and replicate the study on a wider scale at other setting to permit for generalization of the findings. |  |  |